What Destolit (Permethrin) treats: main uses and benefits

Destolit, containing the active ingredient permethrin, is a topical medication primarily used to address infestations caused by specific external parasites. It belongs to a class of medications known as pyrethroids, which work by disrupting the nervous systems of targeted organisms.

Primary Uses

Scabies Treatment

Destolit is most commonly utilized for the treatment of scabies, a skin condition caused by the microscopic mite Sarcoptes scabiei. The medication is designed to eliminate both the mites and their eggs by penetrating the skin where the organisms reside. This helps to resolve the underlying cause of the infestation and prevent further transmission to others.

Head Lice Management

In certain formulations, permethrin is used to treat infestations of head lice (Pediculus humanus capitis). It acts on the nervous system of the lice to paralyze and kill them. While it is effective against live lice, its impact on unhatched eggs may vary, often requiring a comprehensive approach to ensure all life cycles of the parasite are addressed.

Benefits and Clinical Effects

• Targeted Antiparasitic Action: The medication is specifically formulated to target the physiological structures of parasites without significant systemic absorption in humans.
• Relief of Associated Symptoms: By eliminating the parasites, the medication helps to alleviate the secondary symptoms of infestation, such as intense itching (pruritus), skin redness, and inflammation.
• Prevention of Complications: Effective treatment of parasitic infestations helps reduce the risk of secondary bacterial skin infections that can occur due to persistent scratching and skin breakdown.
• Public Health Impact: Addressing individual infestations contributes to breaking the cycle of transmission within households and communities, which is essential for managing the spread of highly contagious parasites like scabies.

Regulatory References

1. NIH MedlinePlus Drug Information

Eligibility for Destolit (Permethrin) Cream 5%

The official eligibility profile for Permethrin is defined by specific population criteria and regulatory restrictions based on government-approved labeling.

The medicine is safe and effective for the treatment of scabies in adults, adolescents, and children starting from two months of age. However, safety and effectiveness have not been established in infants under two months of age. For children between two and 23 months, treatment must be given only under close medical supervision as per EU labeling.

Use during pregnancy is permitted only if clearly needed, and for nursing mothers, regulatory guidance recommends that consideration be given to discontinuing nursing temporarily or withholding the drug. The label also advises caution for patients with a known allergy to ragweed or severe scalp inflammation.

Interactions with other medicines and products

Regulatory documentation indicates that the interaction profile for Destolit (Permethrin) is characterized by a notable absence of known systemic drug-drug interactions. This finding is consistent across official labeling and is attributed to the medication’s topical administration, which results in minimal systemic absorption of the active ingredient.

Documented Topical and Product-Specific Constraints

While systemic interactions are not documented, official regulatory sources do outline specific constraints related to application timing and product material compatibility.

No known interactions with food, alcohol, or herbal products are documented in regulatory prescribing information. The interaction profile is strictly limited to these local and timing-based constraints, reflecting the medication’s intended use as an external ectoparasiticide.

Permethrin's primary mechanism of action involves the highly selective disruption of the voltage-gated sodium channels (NaV) embedded in the nerve cell membranes of target arthropods. The drug acts as an inhibitor, preventing the channels from undergoing normal inactivation and maintaining a prolonged influx of sodium ions. This molecular interaction causes the neuronal membrane to remain in a state of persistent electrical overstimulation (depolarization).

The resulting high-frequency, uncontrolled firing of nerve impulses initiates a destructive cascade throughout the parasite's nervous system. This quickly leads to the exhaustion of motor function, resulting in prostration (immobility) and functional respiratory paralysis, which directly causes the irreversible functional failure of the organism.

This neurotoxic mechanism is selectively constrained in the host (human) because rapid enzymatic hydrolysis by esterases restricts systemic exposure. Conversely, resistance is a mechanism limitation emerging from genetic alterations in the target channel or enhanced parasite detoxification pathways.

How to Use Destolit (Permethrin)

Permethrin, the active ingredient in Destolit, is administered exclusively by the topical route (dermal/cutaneous) and is strictly for external use only. The medication is available in specific strengths to address different parasitic conditions.

Administration and Dosing Schedule

For the treatment of scabies, the standard adult application of the 5% cream involves covering the entire body from the neck to the soles of the feet, typically using around 30 grams. The application should be done on skin that is clean, dry, and cool.

Procedural and Population-Specific Rules

The treatment protocol is defined by procedural requirements that ensure full parasitic contact. For the scabies cream, if the hands are washed during the 8-to-14-hour contact period, reapplication to the hands is mandatory.

Age-group administration rules indicate that Permethrin is approved for use in children 2 months of age and older. For infants under two years and for older adults (over 65), the application area for the 5% cream must be expanded to specifically include the scalp, face, and ears. Furthermore, the overall use protocol includes environmental decontamination of clothing and bedding (e.g., washing at high temperatures or sealing items) as a required measure to prevent re-infestation.

Destolit (Permethrin): Recent Clinical Evidence

Clinical research on Permethrin cream (5%) focuses primarily on its use for treating scabies and pediculosis capitis (head lice). Studies generally aim to evaluate its performance, compare it against alternative treatments, and track changes in parasite susceptibility over time.

Efficacy and Comparative Studies

Controlled trials often compare topical permethrin to oral ivermectin for treating scabies. A review of clinical trials reported similar efficacy between 5% permethrin cream and oral ivermectin after two weeks of administration. In one Phase III trial, participants receiving the drug reported a reduction in pain that averaged 50%. Comparative research also exists to evaluate the use of permethrin in combination with other treatments.

Research into Drug Susceptibility

Research has investigated whether the drug is associated with changes in inflammation and swelling, including the effects related to inflammation. Studies are ongoing to track the prevalence of treatment failure over time, which may indicate a decreasing susceptibility of Sarcoptes scabiei mites to permethrin. These findings emphasize the need for continued monitoring and consideration of alternative treatments, such as in cases of crusted scabies where permethrin may be administered along with an oral agent.

Important Note

This summary describes what research has investigated and reported; it is not yet clear whether the study findings apply universally to all people.

Key Studies & References

1. The Effect of Insecticide Synergists on the Response of Scabies Mites to Pyrethroid Acaricides

Common questions about Destolit (Permethrin) (FAQ)

Q: What is Destolit (Permethrin) used for?

Destolit is a brand name for the medication Permethrin. Permethrin is a topical medication used to treat infestations of scabies (caused by tiny mites) and lice (head lice or pubic lice). It works by paralyzing and killing the mites and lice and their eggs.

Q: How do I use Permethrin cream for scabies?

For the treatment of scabies, a Permethrin 5% cream is typically applied. The cream should be applied to all areas of the body from the neck down to the soles of the feet. For infants and the elderly, the cream may also need to be applied to the scalp, temples, and forehead. The cream is usually left on for 8 to 14 hours, then washed off thoroughly. A single application is often sufficient, but a second application may be needed after 7 to 14 days if living mites are found.

Q: Can Permethrin be used on children?

Permethrin is generally considered safe for use in children. The specific formulation (e.g., cream, lotion) and strength will determine the age at which it can be safely used. For scabies, a Permethrin 5% cream is often approved for use in infants as young as 2 months old. Always consult a healthcare provider for guidance on using this medication in children.

Storage and Disposal of Destolit (Permethrin)

Permethrin cream must be stored at controlled room temperature, maintaining a specific range between 15 C and 30 C (59 F and 86 F). The product must be kept in its original container, which should remain tightly closed, and stored away from excess heat, moisture, and direct light. It is essential to keep Permethrin from freezing to prevent degradation.

Handling and Safety

• Child Safety: It is mandatory to store the medication out of the reach and sight of children to prevent accidental access.
• Disposal: Unused or expired Permethrin should be discarded according to local requirements, which often involves drug take-back programs. If these are unavailable, the medication can be mixed with an undesirable substance and placed in a sealed container before throwing it into household trash.
• Environmental Rule: Disposal instructions specifically caution against releasing the product into drains or waterways.